• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Journal of vitreoretinal diseases

    Journal of vitreoretinal diseases

    JournalISSN 2474-1264eISSN 2474-1272中科院 医学 4区

    年发文量

    研究主题

    论文(1125)

    排序
    1Multifocal Serous Retinal Detachments in a Patient with Herpes Zoster Ophthalmicus
    Mohammad Abdullah,Danielle Cadieux,Amit V. Mishra

    Purpose: To present a unique case of multifocal macular serous retinal detachments in the absence of retinal necrosis. Methods: A single case was reviewed. Results: A 74-year-old man presented with right ocular scotomas and was found to have right macular multifocal serous retinal detachments. This was followed by V1 distribution vesicular rash, pseudodendrites, and mild anterior uveitis consistent with herpes zoster ophthalmicus. The patient was maintained on oral valacyclovir and prednisolone eye drops. Within 2 weeks of his initial presentation, a third cranial nerve palsy developed. The macular serous retinal detachment resolved a month after the onset of his treatment-related symptoms. Conclusions: To our knowledge, this is one of the few case reports describing multifocal macular serous retinal detachment in the absence of retinal necrosis. Further case reports are needed to delineate the natural course of this manifestation.

    2026
    引用
    AI阅读
    加入学术空间
    2Acute Retinal Necrosis in an Infant with Corneal and Macular Scarring: Other Considerations—Reply
    Zuhair Zaidi, Cody Hansen, Sukru Dogan, Angeline L. Wang
    2026
    引用
    AI阅读
    加入学术空间
    3Moving Beyond the Barriers
    Timothy G. Murray
    2026
    引用
    AI阅读
    加入学术空间
    4The Financial Impact of Antivascular Endothelial Growth Factor Drug Durability
    Emily C. Davis, Tom Murickan, Ifrah Khurram,Sean T. Berkowitz, Charles Williard,Akshay S. Thomas

    Purpose: To examine the yearly cost of antivascular endothelial growth factor (anti-VEGF) therapy borne by patients and to assess the major contributors to patient cost. Methods: A retrospective, cross-sectional cost analysis was conducted of 29 250 insured patients in a single practice receiving anti-VEGF injections over a 21-month period between January 1, 2023, and September 30, 2024. Direct costs to the patient were abstracted, including patient copay and patient-responsible portions of imaging, medication, procedure, and visit costs; medication costs were based on average sales price. Transportation cost and opportunity cost associated with missed work were operationalized to estimate indirect costs, using age-stratified employment rates and median earnings from the United States Bureau of Labor Statistics for both patients and accompanying caregivers. Results: The mean (±SD) direct cost per visit was $91.72 ± $22.22. Indirect costs per visit varied by indication, with a mean indirect cost per visit of $97.89 for patients with neovascular age-related macular degeneration (AMD) and $164.44 for patients with diabetic macular edema (DME) for a half day of missed work, and $167.98 and $301.09, respectively, for a full day off work. Indirect costs accounted for 45.37% to 74.86% of total patient cost for a half day off, and 58.76% to 84.50% for a full day off. Relative to the baseline of 12 monthly bevacizumab injections received annually (half-day off scenario), the equivalent total patient cost accrued would correspond to a mean annual number of injections of 9.32 and 10.00 for aflibercept 2 mg, 11.09 and 11.35 for aflibercept 8 mg, and 9.05 and 9.78 for faricimab 6 mg in patients with neovascular AMD and patients with DME, respectively. Conclusions: Patient cost is driven more by visit frequency and its associated indirect costs than by drug price. Less frequent dosing with a more durable agent can therefore lower the total cost experienced by patients despite a higher acquisition price.

    2026
    引用
    AI阅读
    加入学术空间
    5Clinical Characteristics of Subretinal Precipitates in Epidemic Retinitis
    Ankush Kawali,Aayesha Khanum, Raj Hirani,Sai Bhakti Mishra,Padmamalini Mahendradas

    Purpose: To characterize subretinal precipitates in epidemic retinitis and assess their clinical significance as a resolving-stage manifestation. Methods: This retrospective observational study included 113 patients with epidemic retinitis, categorized into 2 groups based on the presence or absence of subretinal precipitates. Clinical, imaging, and treatment data were analyzed. A subgroup presenting within 20 days of symptom onset (n = 76) was categorized and underwent additional assessment. Results: Of 113 patients, 33 (29.2%) had subretinal precipitates (group A), and 80 did not (group B). Subretinal precipitates appeared as yellow granular lesions, mostly in the inferior fundus (78.8%). Optical coherence tomography scans of the subretinal precipitates demonstrated associated subretinal fluid (SRF) in 11 (37.9%) of the 29 available cases. In the 18 remaining cases, a predominantly inferior gravitational distribution, and in some eyes crescentic configuration, raised the possibility of previously resolved SRF. Fundus autofluorescence failed to detect subretinal precipitates. In subgroup analyses, those with subretinal precipitates (n = 22) had a larger retinitis area (mean 17.28 mm 2 versus 11.9 mm 2 ; P = .16) and higher proportion of oral corticosteroid use (40.9% versus 24.1%; P = .23) than those without subretinal precipitates (n = 54), but differences were not significant. Similarly, no significant differences between subgroups with and without subretinal precipitates were observed in SRF height, number of retinitis patches, final visual acuity, or time to resolution of retinitis and macular edema (each P > .05). Subretinal precipitates developed after a mean 1.1 months (range, 0.5–2 months) and resolved after a mean 5.3 months (range, 2–10 months). Conclusion: Subretinal precipitates are a notable resolving-stage manifestation of epidemic retinitis that may persist for months. Recognition of their characteristic features, particularly in patients with a recent febrile illness, may facilitate the diagnosis of resolving epidemic retinitis.

    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 1125 篇论文

    高被引作者

    作者引用发文
    Andre J Witkin2716
    Paul Hahn24011
    Stephen Kim2346
    Netan Choudhry2309
    Timothy G. Murray22729
    Goldberg Roger A2234
    Kevin Blinder22211
    Homayoun Tabandeh2125
    J. Fernando Arevalo2109
    Eric W Schneider2074

    高产作者

    作者引用发文
    Audina Berrocal10739
    Nimesh Patel3130
    Dean Eliott10229
    Timothy G. Murray22729
    Sharon Fekrat5628
    Yoshihiro Yonekawa15126
    Rishi Singh2923
    Harry W. Flynn Jr.8520
    Geoffrey Emerson13019
    John B. Miller10719

    相关期刊

    Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. Albrecht von Graefe's archive for clinical and experimental ophthalmology
    Revista brasileira de oftalmologia
    Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti
    Ophthalmic surgery, lasers & imaging retina
    Taiwan journal of ophthalmology
    Romanian journal of ophthalmology
    Journal of The Korean Ophthalmological Society
    Korean Journal of Ophthalmology
    Ophthalmologica
    Archivos de la Sociedad Española de Oftalmología (English Edition)